Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion type Assertion NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_head.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion description "[SFTPB and SFTPA were down-regulated and the expression of inflammatory cytokines were increased in mice with obstructive lung disease, but levels were largely unaffected by GLP-1R agonist treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_provenance.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion evidence source_evidence_literature NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_provenance.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion SIO_000772 24092637 NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_provenance.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion wasDerivedFrom befree-2016 NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_provenance.
- NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_assertion wasGeneratedBy ECO_0000203 NP1116090.RA171T2u_y0ESNZ0FWDcPEMDGiZbVzHRHvpMBOucrEmng130_provenance.